Vir Biotechnology (VIR) stock forecast for 2026. Forecast tables and graphs.







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…

Vir Biotechnology (VIR) stock forecast for 2026

Updated: March 26, 2024 (09:40)

Sector: Healthcare

The share price of Vir Biotechnology, Inc. (VIR) now

What analysts predict: $32.29
52-week High/Low: $27.48 / $7.72

50/200 Day Moving Average: $10.19 / $12.43

This figure corresponds to the Average Price over the previous 50/200 days. For Vir Biotechnology stocks, the 50-day moving average is the resistance level today.

For Vir Biotechnology stocks, the 200-day moving average is the resistance level today.

Are you interested in Vir Biotechnology, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Vir Biotechnology stock price in 2026. How much will one Vir Biotechnology share be worth in 2026? Is it worth taking profit / loss on VIR stock now or waiting? What are analysts' forecasts for Vir Biotechnology stock?

We forecast Vir Biotechnology stock performance using neural networks based on historical data on VIR stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Vir Biotechnology, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Vir Biotechnology analysts is $32.29. Today 200 Day Moving Average is the resistance level (12.43 $). 50 Day Moving Average is the support level (10.19 $).




Historical and forecast chart of Vir Biotechnology, Inc. stock

The chart below shows the historical price of Vir Biotechnology stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the VIR stock price can be found in the table below.


Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products for the treatment and prevention of serious infectious diseases. He is developing VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus; and VIR-2020 for the prevention of tuberculosis.

Vir Biotechnology (VIR) Forecast for 2026

Month Target Pes. Opt. Vol., %
Jan 11.34 10.23 12.84 20.32 %
Feb 10.82 10.28 11.86 13.32 %
Mar 10.99 10.03 12.44 19.43 %
Apr 12.00 10.25 12.89 20.48 %
May 11.26 9.53 12.97 26.56 %
Jun 12.41 10.89 13.77 20.90 %
Jul 10.30 9.13 11.84 22.96 %
Aug 8.38 7.65 8.72 12.31 %
Sep 8.53 7.29 9.44 22.78 %
Oct 8.57 7.57 9.37 19.20 %
Nov 9.17 7.76 10.60 26.82 %
Dec 10.09 9.52 10.85 12.27 %

Vir Biotechnology information and performance

Vir Biotechnology Address

499 ILLINOIS STREET, SUITE 500, SAN FRANCISCO, CA, US

Market Capitalization: 1 361 123 000 $

Market capitalization of the Vir Biotechnology, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of VIR shares in the company outstanding by the market price of one share.

EBITDA: -640 572 032 $

EBITDA of Vir Biotechnology is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -4.59

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.585
Quarterly Revenue Growth YOY: -0.66
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 4.361

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 1.121

Enterprise Value (EV) /Revenue

EV To EBITDA: 0.0614

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 135032000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Vir Biotechnology price target for 2026 by month


Target values for the price of one Vir Biotechnology share for Jan 2026.

The weighted average target price per Vir Biotechnology share in Jan 2026 is: 11.34.
In Jan, the Positive dynamics for Vir Biotechnology, Inc. shares will prevail with possible monthly volatility of 20.318% volatility is expected.
Pessimistic target level: 10.23
Optimistic target level: 12.84

Target values for the price of one Vir Biotechnology share for Feb 2026.

The weighted average target price per Vir Biotechnology share in Feb 2026 is: 10.82.
In Feb, the Negative dynamics for Vir Biotechnology, Inc. shares will prevail with possible monthly volatility of 13.321% volatility is expected.
Pessimistic target level: 10.28
Optimistic target level: 11.86

Target values for the price of one Vir Biotechnology share for Mar 2026.

The weighted average target price per Vir Biotechnology share in Mar 2026 is: 10.99.
In Mar, the Positive dynamics for Vir Biotechnology, Inc. shares will prevail with possible monthly volatility of 19.435% volatility is expected.
Pessimistic target level: 10.03
Optimistic target level: 12.44

Target values for the price of one Vir Biotechnology share for Apr 2026.

The weighted average target price per Vir Biotechnology share in Apr 2026 is: 12.00.
In Apr, the Positive dynamics for Vir Biotechnology, Inc. shares will prevail with possible monthly volatility of 20.484% volatility is expected.
Pessimistic target level: 10.25
Optimistic target level: 12.89

Target values for the price of one Vir Biotechnology share for May 2026.

The weighted average target price per Vir Biotechnology share in May 2026 is: 11.26.
In May, the Negative dynamics for Vir Biotechnology, Inc. shares will prevail with possible monthly volatility of 26.562% volatility is expected.
Pessimistic target level: 9.53
Optimistic target level: 12.97

Target values for the price of one Vir Biotechnology share for Jun 2026.

The weighted average target price per Vir Biotechnology share in Jun 2026 is: 12.41.
In Jun, the Positive dynamics for Vir Biotechnology, Inc. shares will prevail with possible monthly volatility of 20.901% volatility is expected.
Pessimistic target level: 10.89
Optimistic target level: 13.77

Target values for the price of one Vir Biotechnology share for Jul 2026.

The weighted average target price per Vir Biotechnology share in Jul 2026 is: 10.30.
In Jul, the Negative dynamics for Vir Biotechnology, Inc. shares will prevail with possible monthly volatility of 22.956% volatility is expected.
Pessimistic target level: 9.13
Optimistic target level: 11.84

Target values for the price of one Vir Biotechnology share for Aug 2026.

The weighted average target price per Vir Biotechnology share in Aug 2026 is: 8.38.
In Aug, the Negative dynamics for Vir Biotechnology, Inc. shares will prevail with possible monthly volatility of 12.308% volatility is expected.
Pessimistic target level: 7.65
Optimistic target level: 8.72

Target values for the price of one Vir Biotechnology share for Sep 2026.

The weighted average target price per Vir Biotechnology share in Sep 2026 is: 8.53.
In Sep, the Positive dynamics for Vir Biotechnology, Inc. shares will prevail with possible monthly volatility of 22.785% volatility is expected.
Pessimistic target level: 7.29
Optimistic target level: 9.44

Target values for the price of one Vir Biotechnology share for Oct 2026.

The weighted average target price per Vir Biotechnology share in Oct 2026 is: 8.57.
In Oct, the Positive dynamics for Vir Biotechnology, Inc. shares will prevail with possible monthly volatility of 19.196% volatility is expected.
Pessimistic target level: 7.57
Optimistic target level: 9.37

Target values for the price of one Vir Biotechnology share for Nov 2026.

The weighted average target price per Vir Biotechnology share in Nov 2026 is: 9.17.
In Nov, the Positive dynamics for Vir Biotechnology, Inc. shares will prevail with possible monthly volatility of 26.817% volatility is expected.
Pessimistic target level: 7.76
Optimistic target level: 10.60

Target values for the price of one Vir Biotechnology share for Dec 2026.

The weighted average target price per Vir Biotechnology share in Dec 2026 is: 10.09.
In Dec, the Positive dynamics for Vir Biotechnology, Inc. shares will prevail with possible monthly volatility of 12.267% volatility is expected.
Pessimistic target level: 9.52
Optimistic target level: 10.85



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.